======================================================================
AUDIT REPORT: MeSH Coverage Analysis
======================================================================

## 1. COVERAGE SUMMARY

Total cancer diseases: 3,395
  With MeSH:    627 (18.5%)
  Without MeSH: 2,768 (81.5%)

## 2. EVIDENCE COMPARISON

Metric                               With MeSH    Without MeSH
------------------------------------------------------------
total_evidence                       4,408,726       5,482,592
unique_genes                            23,399          24,921
total_associations                     469,410         553,772
diseases_with_associations                 599           1,946

Evidence share                           44.6%           55.4%

## 3. GHOST TOWNS (zero associations)

Diseases without MeSH AND without any associations: 822
  (29.7% of unmapped diseases)

Sample ghost towns:
  - MONDO_0000271: tuberculous salpingitis
  - MONDO_0000371: oral cavity carcinoma in situ
  - MONDO_0000372: pharynx carcinoma in situ
  - MONDO_0000373: gall bladder carcinoma in situ
  - MONDO_0000374: bile duct carcinoma in situ
  - MONDO_0000375: bronchus carcinoma in situ
  - MONDO_0000381: infiltrating renal pelvis transitional cell carcinoma
  - MONDO_0000382: respiratory system benign neoplasm
  - MONDO_0000383: benign reproductive system neoplasm
  - MONDO_0000407: malignant pleural solitary fibrous tumor

## 4. TOP 20 MISSING DISEASES (by evidence)

Disease                                           Evidence    Genes  Max Score
---------------------------------------------------------------------------
cancer                                           1,748,064   18,298     0.7846
breast cancer                                      786,950   14,440     0.8444
lung cancer                                        226,470   10,655     0.7039
colorectal carcinoma                               221,901   11,409     0.5508
colorectal cancer                                  195,817   11,753     0.7945
gastric cancer                                     180,311    9,777     0.7682
glioblastoma                                        92,739    7,210     0.3443
acute lymphoblastic leukemia                        83,515    5,657     0.7433
urinary bladder carcinoma                           64,997    6,507     0.7871
cervical cancer                                     61,801    6,408     0.6832
chronic myelogenous leukemia                        61,452    4,913     0.8183
oral squamous cell carcinoma                        57,381    6,734     0.3987
liver cancer                                        56,156    7,284     0.4992
breast carcinoma                                    52,689    8,369     0.8350
lymph node metastatic carcinoma                     44,591    5,736     0.5469
papillary thyroid carcinoma                         39,472    6,076     0.5373
nonpapillary renal cell carcinoma                   33,978    5,597     0.6770
endometrial cancer                                  33,666    4,363     0.8093
thyroid cancer                                      28,489    4,279     0.5681
Lynch syndrome                                      28,122      503     0.8880

## 5. MONDO CROSSWALK CHECK

Crosswalk file: data/mondo/mondo_mesh_crosswalk.csv
Total entries in crosswalk: 8,379
Our MONDO diseases missing MeSH: 1,901
Overlap (could be rescued): 1 (0.1%)

## 6. DECISION

WARNING: Major cancer types are in the missing list!
  Found keywords: breast, lung, liver, leukemia

However, this is expected due to vocabulary mismatch:
  - EFO/MONDO research ontologies are more granular than MeSH clinical vocabulary
  - 'breast cancer' in OT ≠ 'Breast Neoplasms' MeSH term (different ID systems)

RECOMMENDATION:
  → Keep strict filtering. MONDO crosswalk provides <1% additional coverage.
  → The 18% with MeSH represents 'clinically mappable' diseases.
  → Missing data is due to ontology granularity, not data quality.

======================================================================